William Lohse

William Lohse is an Investor at Social Starts based in Seattle, Washington, where he specializes in early-stage venture capital allocations within the health technology and longevity sectors. In this capacity, he sources and evaluates startup investments for a firm that manages over $100 million in assets under management. His portfolio management and deal execution involve backing scalable solutions across biotechnology and digital health, including investments in companies such as Rejuveron BioSciences and Overjet. Prior to his current role, Lohse gained experience in venture investing and operations at regional firms including Crystal Ball Ventures, and he holds a degree from the University of Washington. Recently participating in a 2024 funding round for a longevity-focused biotech enterprise, his current focus remains centered on identifying emerging consumer technologies that operate at the intersection of software and human health.